Podcast
OnFocus Podcast: Michael Hoey
April 27, 2022

Francis Medical Founder and Chief Technology Officer, Michael Hoey, was recently featured on OnFocus, a podcast by The Focal Therapy Clinic in the UK.
Click below to hear Michael talk about his personal journey into discovering and developing water vapor therapy for treating the prostate and why he’s so committed to innovating in this space.
Original episode post and transcript
Supplemental Article: Key Trends Driving Progress in Focal Therapy
Learn more about water vapor therapy
Recent Posts
Francis Medical Announces First Commercial Vanquish® Procedure to Ablate Prostate Tissue in the Midwest
websites2026-04-20T17:16:40-05:00April 21st, 2026|
Minneapolis [April 21, 2026] – Francis Medical, Inc., a privately held medical device company based out of Maple Grove, MN, today announced that Aaron Milbank, MD. of Minnesota Urology has successfully completed the first commercial procedure in the Midwest using the Vanquish® Water Vapor Ablation System, a minimally invasive technology designed to ablate targeted prostate tissue.
Francis Medical Announces Further Commercial Expansion of Vanquish® Water Vapor Ablation with First Commercial Procedures to Ablate Targeted Prostate Tissue in the Southeast
websites2026-04-16T08:53:16-05:00April 16th, 2026|
Minneapolis, MN [April 16, 2026] – Francis Medical, Inc., a privately held medical device company, today announced the continued expansion of its U.S. commercial launch with the first commercial procedures performed using the Vanquish® Water Vapor Ablation System in the Southeast, a minimally invasive technology designed to ablate targeted prostate tissue.
Francis Medical Announces First Commercial Vanquish® Procedure on the East Coast for Prostate Tissue Ablation
websites2026-03-25T08:24:11-05:00March 25th, 2026|
Minneapolis, MN [March. 25, 2026] – Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish® Water Vapor Ablation System, a minimally invasive technology designed to ablate targeted prostate tissue while potentially helping to preserve urinary and sexual function.





Refer to the device User Manual for a list of contraindications, warnings, and cautions.
Training: Do not operate the Vanquish System without completing Francis Medical-provided physician training. Untrained operation of the device may lead to improper use. Improper use can result in patient injury or equipment malfunction.